SEC FORM 4
$406,936.07
GeneDx Holdings Corp. (WGS)
Sale of 4,141 shares at $98.2700 per share.
Reporting Person Stueland Katherine · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001689575-26-000032 · filed 2026-09-18 · View filing →